We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare Corporation (THC - Free Report) is well poised for progress on the back of its inorganic growth strategies.
The company’s inorganic growth story highlights acquisitions made over the past many years that have helped it boost its scale of business, expand its existence in new geographies and enhance its operating capacity. Apart from forging links with leading health insurers, Tenet Healthcare has upped its buyout game to enrich its capabilities. In 2018, the company acquired 10 outpatient businesses, three off-campus emergency departments and numerous physician practices. All these strategic buyouts bode well for the company.
Tenet Healthcare is also busy streamlining its operations reflected in a number of divestitures undertaken over the past three years. Last year, it sold nine Aspen facilities in the United Kingdom and eight hospitals in the United States. These deals generated proceeds worth more than $1 billion, which have been used to pay off the company’s debt and maintain its financial liquidity.
In July, it announced its plan to spin off of its Conifer business as an independent publicly traded company. It expects to close the spin-off by the end of second-quarter 2021. The segment has been witnessing a weak performance over the last few quarters. Funds from this deal are also expected to paying down the company’s debts. We also note that the company’s debt levels slipped 1.9% and 1% in 2017 and 2018, respectively.
However, the company has been exposed to declining revenues over the last few quarters due to reduced admissions, inpatient and outpatient surgeries, emergency department visits and total outpatient visits. For 2019, the company expects revenues in the range of $18-$18.4 billion, the mid-point indicating a dip of 0.5% from the reported figure of 2018.
Stocks That Warrant a Look
Some stocks worth a look from the medical sector are HCA Healthcare, Inc. (HCA - Free Report) , Molina Healthcare, Inc. (MOH - Free Report) and Anthem, Inc. .
HCA provides health care services. In the last four quarters, the company delivered average beat of 15.74%.
Molina offers Medicaid-related solutions to meet the healthcare needs of low-income families and individuals. In the trailing four quarters, the company’s average beat was 66.9%.
Anthem works as a health benefits company in the United States. In the last four quarters, the company pulled off average beat of 4.57%.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.6% per year. So be sure to give these hand-picked 7 your immediate attention.
Image: Bigstock
Tenet Healthcare's Strategic Initiatives Aid, Revenues Drag
Tenet Healthcare Corporation (THC - Free Report) is well poised for progress on the back of its inorganic growth strategies.
The company’s inorganic growth story highlights acquisitions made over the past many years that have helped it boost its scale of business, expand its existence in new geographies and enhance its operating capacity. Apart from forging links with leading health insurers, Tenet Healthcare has upped its buyout game to enrich its capabilities. In 2018, the company acquired 10 outpatient businesses, three off-campus emergency departments and numerous physician practices. All these strategic buyouts bode well for the company.
Tenet Healthcare is also busy streamlining its operations reflected in a number of divestitures undertaken over the past three years. Last year, it sold nine Aspen facilities in the United Kingdom and eight hospitals in the United States. These deals generated proceeds worth more than $1 billion, which have been used to pay off the company’s debt and maintain its financial liquidity.
In July, it announced its plan to spin off of its Conifer business as an independent publicly traded company. It expects to close the spin-off by the end of second-quarter 2021. The segment has been witnessing a weak performance over the last few quarters. Funds from this deal are also expected to paying down the company’s debts. We also note that the company’s debt levels slipped 1.9% and 1% in 2017 and 2018, respectively.
However, the company has been exposed to declining revenues over the last few quarters due to reduced admissions, inpatient and outpatient surgeries, emergency department visits and total outpatient visits. For 2019, the company expects revenues in the range of $18-$18.4 billion, the mid-point indicating a dip of 0.5% from the reported figure of 2018.
Stocks That Warrant a Look
Some stocks worth a look from the medical sector are HCA Healthcare, Inc. (HCA - Free Report) , Molina Healthcare, Inc. (MOH - Free Report) and Anthem, Inc. .
HCA provides health care services. In the last four quarters, the company delivered average beat of 15.74%.
Molina offers Medicaid-related solutions to meet the healthcare needs of low-income families and individuals. In the trailing four quarters, the company’s average beat was 66.9%.
Anthem works as a health benefits company in the United States. In the last four quarters, the company pulled off average beat of 4.57%.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.6% per year. So be sure to give these hand-picked 7 your immediate attention.
See them now >>